The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.
The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.
Use of a small-scale filler can result in increased filling efficiency.
Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Process controls get some upgrades to better reflect real-time conditions.
Correct organization and appropriate methods for demonstrating biosimilar comparability are important for supporting regulatory filings.
The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
Glycan analysis provides key information on critical quality attributes that could affect stability, safety and efficacy of a protein therapeutic. Specific needs for understanding the glycosylation profiles change throughout the drug development process, but the requirement for high-resolution glycan information remains the same and is essential to help ensure product quality.
Careful analysis of an unusual precipitate identifies defects.
New study shows China biopharma companies face staffing shortages.
For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.
For cellular materials, new ultra scale-down devices inform large-scale downstream processing techniques.
Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.
FTIR can successfully measure key characteristics of therapeutic proteins in a single step.
FTIR can successfully measure key characteristics of therapeutic proteins in a single step.
***Live: Wednesday, December 2, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET***Learn more about the recent trends in single-use sensors to match bioprocessing needs of bioreactor, fermenters, and mixing applications. Review data from 2-year studies of sensor testing.***On demand available after final airing until Dec. 2, 2021***
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
a capital investment project was required to replace the existing, obsolete high purity water (HPW) generation system and water-for-injection (WFI) generation system with new, reliable technology.
The author discusses the impact of prefilled syringe product contact materials and the filling and stoppering process on protein aggregates.
The authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.
Eurofins' BioPharma Product Testing offers complete CMC Testing Services for the bio/pharmaceutical industry.
The authors re-examine environmental controls in the context of technical advances in manufacturing.